NCT07830212: Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 10 Oct 2026
- Primary completion
- Jun 2028
- Arms
- [68Ga]Ga-OncoACP3 PET Imaging
- Results
- None posted
- 21 Sep 2026: Trial registered
- 10 Oct 2026: Trial started